Results of percutaneous cervical vertebroplasty using an anterolateral approach for cervical spine tumors.

IF 1.1 4区医学 Q3 ORTHOPEDICS

Acta orthopaedica et traumatologica turcica Pub Date : 2022-07-01 DOI:10.5152/j.aott.2022.22035

Ali Fatih Ramazanoğlu, Caner Sarıkaya, Mustafa Umut Etli, Cumhur Kaan Yaltırık, Mehmet Reşid Önen, Sait Naderi

{"title":"Results of percutaneous cervical vertebroplasty using an anterolateral approach for cervical spine tumors.","authors":"Ali Fatih Ramazanoğlu, Caner Sarıkaya, Mustafa Umut Etli, Cumhur Kaan Yaltırık, Mehmet Reşid Önen, Sait Naderi","doi":"10.5152/j.aott.2022.22035","DOIUrl":null,"url":null,"abstract":"Objective: The aim of this study was to report the results of percutaneous vertebroplasty in managing symptomatic osteolytic cervical spine tumors.Methods: This study comprised a retrospective examination of patients who received percutaneous vertebroplasty between 2008 and 2020 for the treatment of tumor-induced symptomatic cervical vertebra involvement. The study summarized the demographics, vertebral levels, pain control rates, clinical results, and complications of percutaneous vertebroplasty using an anterolateral approach.Results: The study sample consisted of 6 female and 2 male patients aged between 20 and 56 (mean=41.37) years. Tumors were located at C2 in 6 cases, at C3 in 1 case, and at C5 in another. The mean volume of poly (methyl methacrylate) injected was 1.5 mL (range: 1-2 mL). Biopsy results showed the presence of metastasis in 5 cases and plasmacytoma in 3. No postoperative complications or mortality were observed after the procedure. Preoperative mean 7.75 visual analog scale score decreased to 2.62. Pain control was reported to be 66.2%.Conclusion: Anterolateral cervical vertebroplasty seems to be a safe, effective, and helpful therapeutic alternative for the treatment of cervical spine tumors. It reduces the risk of infection compared to the transoral method.Level of evidence: Level IV, Therapeutic Study.","PeriodicalId":7097,"journal":{"name":"Acta orthopaedica et traumatologica turcica","volume":"56 4","pages":"268-271"},"PeriodicalIF":1.1000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/21/aott-56-4-268.PMC9612668.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta orthopaedica et traumatologica turcica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/j.aott.2022.22035","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: The aim of this study was to report the results of percutaneous vertebroplasty in managing symptomatic osteolytic cervical spine tumors.

Methods: This study comprised a retrospective examination of patients who received percutaneous vertebroplasty between 2008 and 2020 for the treatment of tumor-induced symptomatic cervical vertebra involvement. The study summarized the demographics, vertebral levels, pain control rates, clinical results, and complications of percutaneous vertebroplasty using an anterolateral approach.

Results: The study sample consisted of 6 female and 2 male patients aged between 20 and 56 (mean=41.37) years. Tumors were located at C2 in 6 cases, at C3 in 1 case, and at C5 in another. The mean volume of poly (methyl methacrylate) injected was 1.5 mL (range: 1-2 mL). Biopsy results showed the presence of metastasis in 5 cases and plasmacytoma in 3. No postoperative complications or mortality were observed after the procedure. Preoperative mean 7.75 visual analog scale score decreased to 2.62. Pain control was reported to be 66.2%.

Conclusion: Anterolateral cervical vertebroplasty seems to be a safe, effective, and helpful therapeutic alternative for the treatment of cervical spine tumors. It reduces the risk of infection compared to the transoral method.

Level of evidence: Level IV, Therapeutic Study.

Abstract Image

查看原文本刊更多论文

前外侧入路经皮颈椎成形术治疗颈椎肿瘤的疗效。

目的:本研究的目的是报告经皮椎体成形术治疗症状性溶骨性颈椎肿瘤的结果。方法:本研究回顾性分析了2008年至2020年间接受经皮椎体成形术治疗肿瘤诱导的症状性颈椎受损伤的患者。该研究总结了采用前外侧入路经皮椎体成形术的人口统计学、椎体水平、疼痛控制率、临床结果和并发症。结果:研究样本为女性6例，男性2例，年龄20 ~ 56岁，平均41.37岁。肿瘤位于C2 6例，C3 1例，C5 1例。注射聚甲基丙烯酸甲酯的平均体积为1.5 mL(范围:1-2 mL)。活检结果显示5例有转移，3例有浆细胞瘤。术后无并发症及死亡。术前平均视觉模拟评分7.75分降至2.62分。疼痛控制为66.2%。结论:前外侧颈椎成形术是一种安全、有效、有益的治疗颈椎肿瘤的方法。与经口方法相比，它降低了感染的风险。证据等级:IV级，治疗性研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta orthopaedica et traumatologica turcica ORTHOPEDICS-

CiteScore

2.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Acta Orthopaedica et Traumatologica Turcica (AOTT) is an international, scientific, open access periodical published in accordance with independent, unbiased, and double-blinded peer-review principles. The journal is the official publication of the Turkish Association of Orthopaedics and Traumatology, and Turkish Society of Orthopaedics and Traumatology. It is published bimonthly in January, March, May, July, September, and November. The publication language of the journal is English. The aim of the journal is to publish original studies of the highest scientific and clinical value in orthopedics, traumatology, and related disciplines. The scope of the journal includes but not limited to diagnostic, treatment, and prevention methods related to orthopedics and traumatology. Acta Orthopaedica et Traumatologica Turcica publishes clinical and basic research articles, case reports, personal clinical and technical notes, systematic reviews and meta-analyses and letters to the Editor. Proceedings of scientific meetings are also considered for publication. The target audience of the journal includes healthcare professionals, physicians, and researchers who are interested or working in orthopedics and traumatology field, and related disciplines.